2Jiangsu Provincial Center for Disease Control and Prevention, Nanjing College of Pharmacy, Third Military Medical University National Engineering Research Center for Immunological Products, Chongqing.
3National Institute for Food and Drug Control.
4Beijing Vigoo Biological, China.
5Jiangsu Provincial Center for Disease Control and Prevention, Nanjing.
A booster dose of EV71 vaccine 1 year after the priming EV71 immunization shows excellent immunogenicity and good safety profile. Clinical Trials Registration: NCT01734408.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/13/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/24625805